Columbia Partners Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
SGA
Columbia Partners Investment Management's NVO Position: Q2 2018 in Review
Columbia Partners Investment Management sold out of Novo Nordisk (NVO) in Q2 2018, closing a stake of 16,036 shares — an estimated $394K sold.
Columbia Partners Investment Management first reported a position in NVO in Q2 2013 and held it in 19 quarters. The position peaked at $15.2M in Q1 2015. 537 funds tracked by Wall St. Rank hold NVO as of Q2 2018.
- Columbia Partners Investment Management reported no remaining Novo Nordisk position as of Q2 2018 after selling out during the quarter.
- Columbia Partners Investment Management sold 16,036 Novo Nordisk shares in Q2 2018, an estimated $394K.
- Columbia Partners Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 19 quarters.
- Columbia Partners Investment Management's Novo Nordisk position peaked at $15.2M in Q1 2015.
- 537 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2018.
Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.